Background
==========

The primary cilium is a microtubule-based sensory organelle that extends from the mother centriole, projecting from the cell surface into the extracellular environment \[[@B1]\]. The assembly of primary cilia is a multistep process initiated by docking of the centriole distal end to a vesicle or membrane patch that subsequently expands and surrounds the axoneme as it elongates by intraflagellar transport (IFT) \[[@B2],[@B3]\]. In many cell types the proximal part of the mature cilium resides in the cytoplasm within an invagination of the plasma membrane known as the ciliary pocket. This region is a unique site for vesicular trafficking by endo- and exocytosis that plays a critical role in ciliary membrane homeostasis and function \[[@B4],[@B5]\].

Primary cilia have become the focus of mounting studies owing to their role in coordinating cellular signaling processes during development and tissue homeostasis, and consequently, their association with a constellation of genetic diseases and syndromes called ciliopathies \[[@B6],[@B7]\]. These include the Bardet-Biedl syndrome (BBS), characterized by obesity, renal anomalies, cognitive defects, post-axial polydactyly, hypogonadism, retinal degeneration, and anosmia \[[@B8]\]. Seven BBS gene products (BBS1, BBS2, BBS4, BBS5, BBS7, BBS8, and BBS9) and BBIP10 reside in a stable complex called the BBSome \[[@B9],[@B10]\]. The BBSome interacts with the Rab8 guanine nucleotide exchange factor Rabin8, as well as several other proteins, and mediates trafficking of membrane proteins to and from cilia \[[@B9],[@B11],[@B12]\]. Although numerous proteins have been implicated in vesicular transport to cilia (reviewed in \[[@B13]\]), Rab8 seems to be a key player in the very first stages of ciliary membrane biogenesis. Rab8 is targeted to the primary cilium during early ciliogenesis followed by a gradual loss from the cilium as the organelle matures \[[@B14]\]. Rab8 is activated by Rabin8 \[[@B15]\], which is recruited to the centrosome and activated by a mechanism involving Rab11 and homologs of the yeast transport protein particle II (TRAPPII) complex subunits \[[@B14],[@B16]\].

Current evidence indicates that the yeast TRAPPII complex consists of a core containing the seven TRAPPI subunits (Trs20, Trs23, Trs31, Trs33, Bet3a, Bet3b, Bet5) as well as the four TRAPPII-specific subunits Trs65, Trs120, Trs130, and Tca17 \[[@B17],[@B18]\]. Functional and biochemical studies have indicated that yeast TRAPPI and TRAPPII complexes are distinct vesicle tethering entities that function in ER-Golgi and intra-Golgi plus endosome-Golgi transport, respectively \[[@B17]\]. Yeast also contains a third TRAPP complex, TRAPPIII, which consists of TRAPPI and Trs85 and functions in autophagy \[[@B17]\]. The composition and function of mammalian TRAPP complexes is less clear, and there is some uncertainty as to how many distinct TRAPP complexes exist in mammalian cells \[[@B17]\]. It is clear, however, that mammalian homologs of the yeast TRAPPI subunits exist in one or more large complexes that also include several homologs of yeast TRAPPII-specific subunits, including Trs120 (TRAPPC9), Trs130 (TRAPPC10), Tca17 (TRAPPC2L) in addition to the Trs130-related TRAPPC11 (C4orf41) and the Trs65-related TRAPPC13 (C5orf44) \[[@B17]-[@B19]\]. Furthermore, although Trs85 seems to be absent from the yeast TRAPPII complex, an ortholog of Trs85 (TRAPPC8) appears to be part of the mammalian TRAPP complex since TRAPPC8 was reported to interact with TRAPPC2 (Trs20 homolog) \[[@B20]\] as well as with TRAPPC2L (Tca17 homolog) and TRAPPC13 \[[@B18]\]. Thus in mammalian cells, TRAPPC8 engages in a complex with both TRAPPI and TRAPPII components. Curiously, TRAPPC8 does not appear to interact with the TRAPPII component TRAPPC9 \[[@B14],[@B20]\], suggesting the existence of distinct TRAPPII-like complexes in mammalian cells. Mammalian TRAPPC8 differs from yeast Trs85 in that it contains a C-terminal extension related to the C-terminus of TRAPPC9, which may explain its association with TRAPPII-specific subunits \[[@B18]\].

Similar to yeast TRAPP complexes, mammalian TRAPP has been implicated in various vesicle trafficking pathways \[[@B17]\]. For example, it was shown that depletion of TRAPPC3, TRAPPC9, or TRAPPC10 in cultured cells impaired primary ciliary membrane biogenesis by inhibiting Rabin8 recruitment to the centrosome \[[@B14]\]. While the possible roles of other TRAPP components in ciliogenesis are unclear, several additional proteins involved in ciliary membrane biogenesis interact with Rab8/Rabin8 (reviewed in \[[@B13]\]). These include the centriole distal appendage protein Cep164 \[[@B21]\] and components of the exocyst complex \[[@B22]\] as well as oculocerebrorenal syndrome of Lowe protein, OCRL1, mutations in which cause a rare X-linked disorder characterized by mental retardation, renal tubulopathy, and congenital cataracts \[[@B23]\]. OCRL1 resides in complexes with various Rab proteins \[[@B24],[@B25]\], with preference for Rab8a, via a binding interface consisting of one α-helix and an adjacent ASH (ASPM, SPD-2, Hydin) domain \[[@B26]\], a novel family of remote homologs of the immunoglobulin (Ig)-like seven-stranded beta sandwich fold superfamily of the nematode major sperm proteins (MSPs) \[[@B27],[@B28]\]. Although poorly defined at present, the MSP fold is believed to form a protein-protein interaction interface involved in cellular signaling and trafficking activities \[[@B28],[@B29]\]. A previous computational survey identified 13 human ASH-containing proteins \[[@B27]\], all of which are confined to three subcellular compartments, namely the centrosome, Golgi, and the cilium, suggesting that the ASH domain is involved in cilia-related functions \[[@B27]\]. Indeed, OCRL1 was recently shown to be required for ciliogenesis and to promote protein trafficking to the primary cilium via a Rab8 and IPIP27/Ses-dependent mechanism \[[@B30]\]. Another ASH-domain-containing protein, the hydrocephalus-associated protein, Hydin, is required for formation of central pair projections of motile cilia and, in turn, for regulating ciliary motility \[[@B31]-[@B33]\], whereas the ASH domain-containing ASPM protein is a centrosomal and microtubule-associated protein that causes microcephaly when defective or absent \[[@B34]\].

We here revisit the ciliary family of ASH domain-containing proteins in humans and yeast and unveil the existence of ASH domains in several members of the TRAPP complex family of proteins. Our database searches identify conserved ASH domains in the C-terminus of mammalian TRAPPC8, -9, -10, -11, and -13, as well as in the yeast TRAPPII complex proteins Trs65, Trs120, and Trs130, none of which were previously assigned any protein structure. We find that the ASH domain in most of these proteins is preceeded by an N-terminal region containing long α-helical matrices exhibiting high levels of helicity and TPR repeat propensity. We further provide evidence that the ASH domains of TRAPPC10 and TRAPPC11 localize to the centrosome when expressed as fusion proteins in mammalian cells and that their expression leads to defects in microtubule organization. Finally, we find that endogenous TRAPPC8 localizes to the centrosome/basal body in cultured cells, and that TRAPPC8 depletion impairs ciliogenesis and targeting of GFP-Rabin8 to the centrosome. Our results corroborate the notion that the ASH domain is involved in microtubule- and cilia-related processes and provide insight into the mechanism by which mammalian TRAPPII homologs target to the centrosome/basal body. Our results further suggest that the yeast TRAPPII complex and its mammalian counterpart are evolutionarily related to the bacterial periplasmic trafficking chaperone PapD of the usher pili assembly machinery \[[@B35]\].

Methods
=======

Bioinformatics
--------------

Profile-to-profile hidden Markov model (HMM)-HMM searches against the PFAMA database (<http://pfam.sanger.ac.uk>) were performed using HHpred \[[@B36],[@B37]\] with default settings. Multiple sequence alignments (MSA) were generated using MAFFT \[[@B38],[@B39]\], edited in Jalview \[[@B40]\], and the consensus of the alignment calculated and colored using ClustalX, as implemented in Jalview. Secondary structure information and structural alignment were predicted using HHpred \[[@B37]\]. For homology modeling of three-dimensional (3D) structures, Modeller \[[@B41],[@B42]\] was employed and templates were chosen based on highest probability and significantly low E value. Discovery Studio 3.5 Visualizer was used for analysis of resulting 3D model coordinates.

PCR and cloning procedures
--------------------------

For generation of plasmids coding for Myc-tagged ASH domains from human TRAPPC10 (amino acid residues 1000-1259) and TRAPPC11 (residues 701-1133; transcript variant 1), the corresponding cDNA regions were PCR-amplified from retinal pigment epithelial cell cDNA \[[@B43]\] by standard procedures using forward (CA*GAATTC*TCCCCATCTACAGCAAGCAGTC for TRAPPC10; CA*GAATTC*TCTTAAATTGGCAGGGAGGAGGAGGA for TRAPPC11) and reverse (CA*GGTACC*TCATGTTACACTGACTTCCAGG for TRAPPC10; CA*GGTACC*TCATGCAGCAGCAATAGAGGTAT for TRAPPC11) primers containing *Eco*R1 and *Kpn*1 restriction sites (italics), respectively. The PCR products were cloned into pCMV-Myc (Clontech laboratories, Inc.) and transformed into *Escherichia coli* DH10α using standard procedures. Plasmids from recombinant bacteria were purified using endotoxin-free plasmid DNA purification kit (NucleoBond Xtra Midi EF) from Macherey-Nagel and the inserts sequenced at Eurofins MWG Operon.

Mammalian cell culture
----------------------

The retinal pigment epithelial (RPE) cells used (lab stock) were derived from the immortalized hTERT RPE-1 cell-line and cultured as described previously \[[@B43]\].

Immunofluorescence microscopy
-----------------------------

For immunofluorescence microscopy analysis of cells expressing ASH domain fusion proteins RPE cells were seeded on coverslips, transfected with plasmids encoding Myc-TRAPPC10-ASH or Myc-TRAPPC11-ASH (see above) and serum starved for 24 h. Cells were fixed with methanol or 4% PFA and subjected to immunofluorescence microscopy as described \[[@B43]\] using rabbit monoclonal antibody specific for Myc (1:500 dilution; Cell Signaling) and mouse monoclonal antibodies specific for α-tubulin (1:4,000 dilution; Sigma), acetylated-tubulin (1:4,000 dilution; Sigma) or p150^Glued^ (1:250 dilution; BD Biosciences). To study the localization of endogenous TRAPPC8 RPE cells were seeded on coverslips and incubated in serum-depleted medium for 24 h to induce cilia formation. Cells were fixed with methanol and subjected to immunofluorescence microscopy as described \[[@B43]\] using rabbit polyclonal antibody specific for TRAPPC8 (1:100 dilution; Sigma), rat monoclonal antibody specific for EB3 (1:300 dilution; Absea clone KT36), and mouse monoclonal antibodies specific for acetylated-tubulin (1:5,000 dilution; Sigma) and p150^Glued^ (1:500 dilution; BD Biosciences). Imaging was performed with a motorized Olympus BX63 upright microscope equipped with a DP72 color, 12.8 megapixel, 4140 × 3096 resolution camera and differential interference contrast (DIC). The software used was Olympus CellSens dimension. Images were processed for publication using Adobe Photoshop CS4 version 11.0.

TRAPPC8 knock-down, GFP-Rabin8 expression, SDS-PAGE, and western blot
---------------------------------------------------------------------

For TRAPPC8 knock-down experiments, RPE cells were seeded and subjected to transfection with 100 nM esiRNA specifically targeting TRAPP8C (Cat\# EHU065741; Sigma) or control siRNA (5′-UAA UGU AUU GGA ACG CAU ATT-3′; Eurofins MWG Operon) using DharmaFECT Duo Transfection Reagent (Thermo Scientific) essentially as described \[[@B43]\]. Cells were then incubated in serum-depleted medium for 24 h and either PFA-fixed and analyzed by immunofluorescence microscopy with acetylated tubulin antibody as described above or lysed using 0.5% SDS; the lysates were subsequently analyzed by SDS-PAGE and western blotting as described previously \[[@B44]\]. Rabbit polyclonal antibody specific for TRAPPC8 (1:500 dilution; Sigma) and mouse monoclonal antibody specific for α-tubulin (1:2,000 dilution; Sigma) were used for western blot. Blots were scanned and processed for publication using Adobe Photoshop CS6 version 13.0 and Adobe Illustrator CS6 version 16.0.0. For experiments with GFP-Rabin8 plasmid RPE cells were seeded and transfected with 100 nM esiRNA or control siRNA as described above. After 30 h, cells were transfected with plasmid encoding GFP-Rabin8 \[[@B14]\] for another 16 h. Prior to fixation with PFA cells were serum starved for 1 h and subjected to immunofluorescence microscopy with p150^Glued^ antibody as described above, and the number of GFP-positive centrosomes in GFP-Rabin8 expressing cells was scored.

Results
=======

Identification of ASH domains in the C-terminus of known and putative TRAPPII components
----------------------------------------------------------------------------------------

Sequence homologies between the ASH domain and yeast TRAPPII-specific components and their mammalian counterparts were readily attained by searching the PFAM database of protein families \[[@B45]\] using the human DLEC1 amino acid sequence as a search query in the HHpred server (<http://toolkit.tuebingen.mpg.de/hhpred>) (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1). We chose DLEC1 as search query because this protein was identified with high confidence as an ASH domain-containing protein in a bioinformatics analysis \[[@B27]\]. However, the molecular function of DLEC1 is largely unknown. Specifically, a HMM based profile-to-profile search with a minimal portion of human DLEC1 (amino acids 769-980; \[[@B27]\]) carrying the second ASH module produced high probability sequence similarities to the TRAPPC9-Trs120 family of the PFAM entry PF08626 (local search algorithm: probability 97.47, E = 0.035), as well as to a profile of bacterial PapD/FimC (PF14874) and its eukaryotic derivative, the MSP domain (PF00635) (both having E \< 1 × 10^-5^) \[[@B28]\]. Since we found that the ASH and MSP domains resemble the same conserved domain family, we have chosen to use the terms ASH and MSP interchangeably. An analogous search using the global search mode recovered essentially the same matches yielding higher score parameters to TRAPPC9-Trs120 (probability 98.10, E = 3.6 × 10^-5^). This indicates that the family of TRAPPII proteins, encompassing metazoan TRAPPC9 homologs and yeast Trs120, bear homology by sequence to the ASH domain. Indeed, a reciprocal profile-to-profile search seeded with, for example, yeast Trs120 (amino acids 660-948) identified, besides TRAPPC9-Trs120, the PapD family as the highest scoring hit (local/global search modes: probability 97.78/97.22, E = 8.6 × 10^-4^/4.4 × 10^-4^). Likewise, using a longer stretch of the Trs120 C-terminus (amino acids 486-1166) as a search query, employing three MSA generation iterations, we identified a portion of human Hydin (amino acids 361-892) containing three ASH domains (global search probability 96.50, E = 0.017), supporting the existence of the ASH domain in Trs120/TRAPPC9. Interestingly, this search also identified remote sequence similarities to additional or putative TRAPPII subunits, including human TRAPPC13/C5orf44 (local probability 99.41, E = 9.2 × 10^-12^), C4orf44/Gryzun (TRAPPC11) (local probability 99.39, E = 1.1 × 10^-9^) as well as TRAPPC8 (local probability 100, E = 7.8 × 10^-32^). These findings raise the possibility that mammalian TRAPP possesses multiple paralogous ASH domain-bearing components.

Encouraged by the above findings, and to uncover the full repertoire of Trs120/TRAPPC9 homologs bearing ASH domains in humans and yeast, we decided to validate the occurrence of this domain in each of the known or putative TRAPPII-specific subunits. In each instance, the minimal C-terminal portion displaying sequence homology to ASH was retrieved and used as a query in HHpred (<http://toolkit.tuebingen.mpg.de/hhpred>). Remarkably, we were able to show the presence of one or two ASH domains in three of the subunits of yeast TRAPPII (Trs65, -120, and -130) and their human counterparts TRAPPC9, -10, -11, and -13 as well as TRAPPC8 (Figure [1](#F1){ref-type="fig"}). These searches yielded significant local E values in the range of 10^-2^-10^-3^ with the exception of TRAPPC10 showing more remote similarity to the ASH (probability 91.01 and E = 0.85). Collectively, these searches show that almost all the known and putative TRAPPII-specific components exhibit genuine homology to the ASH/MSP domain (Figure [1](#F1){ref-type="fig"}). Further, using the Modeller server (<http://toolkit.tuebingen.mpg.de/modeller>) we could predict a tertiary structure model of each identified ASH domain that was compatible with the solved 3D structure of the human OCRL1 ASH domain \[[@B26]\] (Figure [2](#F2){ref-type="fig"} and data not shown). We also confirmed the human OCRL1 ASH region as the best, and statistically most significant, match by mining the Protein Data Bank (PDB) \[[@B46]\] for similar 3D structures, thus reinforcing our predictions of the existence of this domain in TRAPPC8, -9, -10, -11, and -13.

![**Identification of a TPR-ASH domain structure in TRAPPII complex subunits. (A)** Domain architecture of known and putative TRAPPII subunits, represented by human TRAPPC8, -9, -10, -11, and -13. Reciprocal HHpred searches identified the regions containing ASH domains, as shown. TRAPPC8 (region 912-1032; local probability 96.98, E = 0.0038), TRAPPC9 (region 725-795; local probability 97.20, E = 0.002), TRAPPC11 (region 748-1133; local probability 96.69, E = 0.012), TRAPPC13 (region 71-150; probability = 97.21, E = 0.0013). The TRAPPC10 C-terminus is more distantly related to the ASH domain. Three iterative HMM-HMM searches of TRAPPC10 region 1072-1158 (local search mode) produced a match to PapD with probability 91.01 and E = 0.85. TPR repeat regions were identified by HHpred and TPRpred (see main text). A minimum of two TPR repeats was used as an exclusion criterium. Human TRAPPC10 was only shown to contain TPR repeats in HHpred. **(B)** Multiple sequence alignment of ASH domains identified previously \[[@B27]\] and here. Sequences were aligned using MAFFT (<http://myhits.isb-sib.ch/cgi-bin/mafft>) here only representing the partial ASH regions surrounding the conserved asparagine (N). The secondary structure, predicted by HHpred, is shown above the alignment (arrows indicating β-sheets) and the derived consensus amino acids of the alignment are shown below. Consensus abbreviations were obtained in Jalview (<http://www.jalview.org/>): hydrophobic (h, blue), polar (light green), acidic (violet), glycine (brown), proline (brown green), and asparagine (dark green). For simplicity, only representative proteins found in the first iterative HHpred search with Trs120 against human PFAM profiles are aligned. The representative sequences include: *Schizosaccharomyces pombe* (Sp) Trs120, human (Hs) TRAPPC8, -9, -11, and -13, as well as human DLEC1, Hydin, CCDC108, Cxorf22, RW1, and the PFAM entry of bacterial PapD (as displayed by HHpred). For a graphical output showing results of the initial HHpred search with human DLEC1 (residues 769-980) as search query, see Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1.](2046-2530-3-6-4){#F1}

![**Predicted 3D structure of the TRAPPII ASH domain. (A)** Known structure of a Hydin ASH domain (PDB (<http://www.pdb.org>) entry 2E6J). **(B)** Model of the TRAPPC9 ASH structure constructed using Modeller (<http://toolkit.tuebingen.mpg.de/modeller>) based on the structure of the OCRL1 ASH domain (PDB (<http://www.pdb.org>) entry 3QBT). **(C)** The solved structure of the bacterial PapD protein is shown for comparison (PDB (<http://www.pdb.org>) entry 2WMP). **(D)** The OCRL1 ASH structural coordinates were obtained at PDB.org (3QBT).](2046-2530-3-6-5){#F2}

Identification of TPR repeats in the N-terminus of known and putative TRAPPII components
----------------------------------------------------------------------------------------

Interestingly, Trs120 based profile-profile searches also revealed significant similarities of its N-terminus to the N-termini of other TRAPPII components as well as to human Rapsyn (probability 97.75, E = 0.0096) that consist of short tracts of tetratricopeptide (TPR) repeats, indicating that Trs120 bears TPR repeats in its N-terminus. To further examine the TRAPPII complex subunits for the co-occurrence of TPR repeat conformations, the N-terminal portion of each polypeptide sequence was probed for the presence of high α-helical content coinciding with TPR repeat propensity. With the exception of TRAPPC13, all human and yeast TRAPPII subunits were predicted to harbor amino termini containing long α-helical matrices exhibiting high levels of helicity (\>50%) and high TPR repeat propensity, as judged by secondary degrees structure prediction algorithms at the HNN server \[[@B47]\] and searches with the TPRpred server \[[@B48]\]. These results suggest that TRAPPC8, -9, -10, and -11 consist of an α-solenoid bearing stretches of multiple TPR repeats followed by one or two ASH domains in the C-terminus (Figure [1](#F1){ref-type="fig"}).

The ASH domains of TRAPPC10 and TRAPPC11 target to the centrosome and affect microtubule organization
-----------------------------------------------------------------------------------------------------

Since the ASH domain seems to be confined to proteins that localize to the centrosome, Golgi, and the cilium \[[@B27]\], and to validate our bioinformatics results, we analyzed the subcellular localization of two of the identified ASH domains, the ASH domain of TRAPPC10 and the second ASH domain of TRAPPC11 (Figure [1](#F1){ref-type="fig"}). To this end, plasmids coding for Myc-tagged versions of these two domains were expressed in RPE cells, the cells subjected to 24 h of serum starvation to induce ciliogenesis, and analyzed by immunofluorescence microscopy using rabbit antibodies specific for Myc as well as mouse antibodies against α-tubulin, acetylated-tubulin, or p150^Glued^ to mark the microtubule cytoskeleton, cilia, and centrosome, respectively. As shown in Figure [3](#F3){ref-type="fig"}, both Myc-ASH domain fusion proteins localized at the centrosome as well as to specific punctae overlapping the nucleus. Moreover, cells overexpressing the Myc-ASH fusion proteins frequently displayed bundles of microtubules surrounding the nucleus (Figure [3](#F3){ref-type="fig"}A, B), indicating that overexpression of the ASH domain perturbs microtubule dynamics/organization. We conclude that at least two of the identified ASH domains can target to the centrosome.

![**The TRAPPC10 and TRAPPC11 ASH domains target to the centrosome and affect microtubule organization.** RPE cells expressing Myc-TRAPPC10-ASH or Myc-TRAPPC11-ASH were serum-starved for 24 h, fixed with methanol **(A)** or PFA **(B, C)** and stained with rabbit monoclonal antibody against Myc and mouse monoclonal antibody against α-tubulin (tub), acetylated tubulin (Ac tub) or p150^Glued^, as indicated. DNA was stained with DAPI. Note that the Myc-ASH fusion proteins localize to the centrosome (arrowheads) and basal body (asterisk), and cause bundling of microtubules (open arrow). An example of a primary cilium, stained with Ac tub antibody, is indicated with a closed arrow. Punctate staining near the nucleus can be seen in some cells expressing Myc-ASH fusion proteins (green staining in panel **A)**. Insets show enlargement of the centrosome area.](2046-2530-3-6-1){#F3}

Localization of endogenous TRAPPC8 to the centrosome/basal body
---------------------------------------------------------------

To further investigate the link between the ASH domain and centrosome/basal body localization, we next investigated the subcellular localization of endogenous TRAPPC8 in cultured RPE cells. TRAPPC8 has not previously been shown to localize to centrosomes and cilia; commercially available TRAPPC8 antibody recognized a prominent band of appropriate size in western blot analysis of RPE cell lysate that was reduced in intensity upon treatment of cells with TRAPPC8-specific siRNA (Figure [4](#F4){ref-type="fig"}A, B). Interestingly, immunofluorescence microscopy analysis of serum-starved RPE cells with the TRAPPC8 antibody showed prominent staining of the centrosome/basal body, as revealed by co-staining with antibodies against p150^Glued^, EB3, or acetylated tubulin (Figure [5](#F5){ref-type="fig"}). Thus TRAPPC8 localizes to the centrosome/basal body. We also used similar approaches to investigate whether TRAPPC11 and TRAPPC13 localize to the basal body/centrosome, but immunofluorescence microscopy analyses with commercially available antibodies against these two proteins were unsuccessful, and hence their subcellular localization could not be addressed. To test if TRAPPC8 is involved in ciliogenesis, as reported previously for TRAPPC3, TRAPPC9, and TRAPPC10 \[[@B14]\], we depleted TRAPPC8 from RPE cells using esiRNA (Figure [4](#F4){ref-type="fig"}B), subjected cells to serum depletion for 24 h to induce ciliogenesis, and analyzed ciliation frequency by immunofluorescence microscopy with acetylated tubulin antibody. Interestingly, this analysis revealed a significant reduction in ciliation frequency of TRAPPC8-depleted cells compared to mock-transfected control cells (approximately 33% and 63% ciliated cells, respectively; Figure [4](#F4){ref-type="fig"}C). To investigate if the observed reduction in ciliation frequency of TRAPPC8-depleted cells was linked to defective targeting of Rabin8 to the centrosome, as reported previously for TRAPPC3, TRAPPC9, and TRAPPC10 \[[@B14]\], we expressed GFP-Rabin8 \[[@B14]\] in RPE cells depleted for TRAPPC8 and in mock-transfected control cells. Interestingly, immunofluorescence microscopy of these cells using p150^Glued^ antibody as centrosome marker revealed that TRAPPC8 depleted cells were impaired in their ability to recruit GFP-Rabin8 to the centrosome (Figure [4](#F4){ref-type="fig"}D). Thus TRAPPC8 localizes to the centrosome/basal body and appears to be required for ciliogenesis, likely via recruitment of Rabin8 to the centrosome. Further experiments will be required to determine whether TRAPPC8 functions together with or separately from the TRAPPII complex in this process.

![**Western blot analysis and esiRNA-mediated depletion of TRAPPC8. (A)** Western blot analysis of whole cell lysate from RPE cells, probed with rabbit polyclonal TRAPPC8 antibody. Molecular mass markers are shown in kDa to the left. **(B)** Western blot analysis of lysates from RPE cells treated with TRAPPC8-specific esiRNA or mock-transfected control cells. Blots were probed with antibodies specific for TRAPPC8 or α-tubulin (loading control). **(C)** Quantification of cilia in RPE cells depleted for TRAPPC8 using TRAPPC8-specific esiRNA. The cells were fixed with PFA and stained with acetylated tubulin antibody for visualization of cilia. Three independent experiments were conducted with 100 cells counted per condition per experiment. *P* value (\*) = 0.0227 using unpaired *t* test. **(D)** Selected immunofluorescence micrographs of GFP-Rabin8 expressing mock-transfected control cells or cells depleted for TRAPPC8. Cells were first treated with mock or TRAPPC8-specific esiRNA and then transfected with GFP-Rabin8 plasmid. Following serum starvation for 1 h, cells were fixed with PFA and stained with antibody against p150^Glued^ to mark the centrosome (red). In Mock-transfected control cells, 92% of GFP-Rabin8 expressing cells showed GFP-Rabin8 at the centrosome whereas only 60% of the GFP-Rabin8 expressing TRAPPC8-depleted cells showed centrosomal GFP-Rabin8 localization (50 cells analyzed per condition).](2046-2530-3-6-3){#F4}

![**Endogenous TRAPPC8 localizes to the centrosome/basal body.** RPE cells were serum-starved for 24 h, fixed with methanol (upper two panels) or PFA (lower panel) and stained with rabbit polyclonal antibody against TRAPPC8 (green) and mouse monoclonal antibody against p150^Glued^, rat monoclonal antibody against EB3 or mouse monoclonal antibody against acetylated tubulin (Ac tub), as indicated (red). DNA was stained with DAPI. Arrowheads and asterisks point to the centrosomes/basal bodies. Closed arrow indicates a primary cilium.](2046-2530-3-6-2){#F5}

Discussion
==========

Activation of the Rab11-Rabin8-Rab8 axis relies on the highly conserved Golgi TRAPPII subunits TRAPPC9 and TRAPPC10, which associate and co-localize with Rabin8 to ensure its targeting to the centrosome and proper biogenesis of the ciliary membrane \[[@B14]\]. Although poorly defined in mammals, yeast data have revealed a division of labor between the two analogous TRAPPI and TRAPPII complexes \[[@B17]\]. Yeast TRAPPI consists of seven subunits (Trs20, Trs23, Trs31, Trs33, Bet3a, Bet3b, Bet5) and the TRAPPII complex includes four additional proteins, Trs65, Trs120, Trs130, and Tca17, which comprise the putative yeast orthologs of mammalian TRAPPC13, TRAPPC9, TRAPPC10/11, and TRAPPC2L, respectively \[[@B17]-[@B19]\]. TRAPPI mediates ER to early Golgi trafficking whereas the TRAPPII complex performs late Golgi vesicle tethering for a diverse group of membrane proteins \[[@B17]\]. Despite a wealth of functional insight, and although the overall architecture of the TRAPPII complex has been determined \[[@B49]\], the molecular structure of individual TRAPPII complex subunits and the biochemical basis for how they recognize their targets remain unknown.

We here shed the first light on the domain organization of conserved TRAPPII complex-specific subunits in yeast their human orthologs with implications for the ciliary targeting and evolution of this protein complex. Based on profile-to-profile searches and structural threading we propose that the TRAPPII-specific subunits are paralogous entities that bear conserved domain arrangements consisting of amino terminal arrays of TPR repeats followed by a C-terminal ASH module (except for TRAPPC13, which does not appear to contain an amino terminal TPR repeat region). Among the subunits that adopt such a TPR-ASH bipartite arrangement, we find the yeast TRAPPII Trs120, Trs130, and Trs65 subunits as well as human TRAPPC8, 9, 10, and 11. In addition, we find that these TRAPP components, as with the MSP modules of VAPB \[[@B28]\], show remote homology to the bacterial periplasmic trafficking chaperone PapD of the usher pili assembly machinery \[[@B35]\] (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}, and Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1). We therefore propose an ancient relationship between the gram-negative bacterial secretory SecY-dependent pili assembly pathway and the eukaryotic TRAPPII-facilitated vesicular trafficking pathway from the late Golgi to the membrane of the primary cilium (Figure [6](#F6){ref-type="fig"}).

![**The TRAPPII complex may have evolved from bacterial PapD chaperone of the usher pili assembly pathway.** Cartoon showing the bacterial and eukaryotic trafficking pathways guided by the PapD and TRAPPII complex, respectively. In bacteria, PapD functions as a chaperone that restrains and tethers the polypeptides to the PapC usher pore complex as they convey across the periplasm between the inner- and outer membrane \[[@B35]\]. In eukaryotes, the TRAPPII particle with its distinct Trs120, Trs130, and Trs65 components (yeast), as compared to the TRAPPI complex, targets proteins in late Golgi trafficking to the outer membrane. In metazoans a similar function of the TRAPPII complex is believed to traffic vesicular cargo to the plasma membrane and cilium \[[@B17]\]. TRAPPC8 may also be involved in Rabin8 centrosome targeting, but it is unclear whether TRAPPC8 functions together with or separately from the TRAPPII complex in this process.](2046-2530-3-6-6){#F6}

Our immunofluorescence microscopy analysis showing that heterologously expressed TRAPPC10-ASH and TRAPPC11-ASH localize to the centrosome and affect microtubule organization (Figure [3](#F3){ref-type="fig"}), as well as our observation that endogenous TRAPPC8 localizes to the centrosome (Figure [5](#F5){ref-type="fig"}) and is required for ciliogenesis (Figure [4](#F4){ref-type="fig"}), strongly suggests that the ASH domain constitutes a centrosome-targeting module. How might the ASH domain of TRAPP components confer targeting to the centrosome? One possibility is that the ASH domain directly binds microtubules, since the *Drosophila* ASPM homolog abnormal spindle, asp, binds microtubules within a 512 amino acid region that contains the ASH domain \[[@B50]\]. Alternatively, it is possible that the TRAPP ASH domain interacts with centrosome-specific Rab GTPases such as Rab8. Structural studies of the ASH domain-containing OCRL1 protein showed that this domain directly interacts with Rab8a \[[@B26]\], and TRAPPC9 and TRAPPC10 were previously shown to interact with Rabin8 \[[@B14]\], a GTP exchange factor for Rab8 \[[@B15]\]. Finally, a polypeptide comprising the last 211 amino acid residues of TRAPPC9, which includes all of the second ASH domain (Figure [1](#F1){ref-type="fig"}A), was shown to interact directly with the NIK and IKKβ-binding protein NIB \[[@B51]\], indicating that the TRAPP ASH domain could also be mediating such interactions. Clearly, more studies are needed to understand how the ASH domain engages in interactions with different binding partners. Such studies will be facilitated by the results of our bioinformatics analysis presented here.

Even though more studies are needed to identify the mechanism by which the ASH domain targets to the centrosome/basal body, several reports indicate that the ASH domains identified here for TRAPPII components are functionally important. For example, a recent report identified a splice site mutation before exon 18 in *TRAPPC9,* leading to formation of a truncated TRAPPC9 polypeptide ending at amino acid 967, in two patients with a Prader-Willi-like phenotype \[[@B52]\], signifying that the C-terminal region of TRAPPC9 containing the second ASH domain (Figure [1](#F1){ref-type="fig"}A) is functionally important. Similarly, a mutation in *TRAPPC11* leading to a single amino acid change in the region between the two predicted ASH domains (pGly980Arg; Figure [1](#F1){ref-type="fig"}A) was identified in patients with myopathy, infantile hyperkinetic movements, ataxia, and intellectual ability \[[@B53]\], demonstrating the functional importance of this region.

The identification of ASH/MSP domains in the TRAPPII subunits underpins their previously proposed function in ciliary membrane biogenesis \[[@B14]\] at the molecular level, and corroborates the idea that the ASH domain is associated with cilia-related functions \[[@B27]\]. The presence of an amino terminal α-helical TPR repeat region is also a hallmark of numerous ciliary proteins \[[@B54]\], and hence the presence of such a TPR repeat region in the N-terminus of most TRAPPII subunits (Figure [1](#F1){ref-type="fig"}) is in line with their ciliary function. As with the ASH domain, the TPR repeat region also seems to be functionally important because mutation leading to deletion of residues 372-429 of TRAPPC11 were shown to impair post-Golgi trafficking and to cause myopathy, infantile hyperkinetic movements, ataxia and intellectual disability in patients \[[@B53]\].

Although we found TRAPPC8 to be localized to the centrosome/basal body (Figure [5](#F5){ref-type="fig"}) and to be required for ciliogenesis and centrosomal targeting of GFP-Rabin 8 (Figure [4](#F4){ref-type="fig"}) TRAPPC8 has not been reported to be part of the TRAPPII complex (see Background). Thus it remains to be determined if the observed effects of TRAPPC8 depletion in ciliogenesis involve interaction with TRAPPII components such as TRAPPC9 and TRAPPC10 \[[@B14]\]. In yeast TRAPPC8 (Trs85) functions in autophagy \[[@B17]\]. Interestingly, two recent studies indicated a functional link between primary cilia and autophagy \[[@B55],[@B56]\], suggesting that TRAPPC8 function at the centrosome/basal body could also be linked to autophagy. In future studies it will be interesting to investigate this further and to investigate possible cilia-related function for TRAPPC11 and TRAPPC13.

Conclusions
===========

Our results suggest that the TRAPP subunits TRAPPC8, -9, -10, and -11 subunits as well as their yeast counterparts exhibit a domain structure consisting of an N-terminal α-solenoid with TPR repeats followed by a C-terminus harboring one or two ASH domains. Immunofluorescence microscopy analysis as well as esiRNA-mediated silencing of TRAPPC8, indicated that the ASH domain is a bona fide centrosome targeting domain, and that TRAPPC8 has a novel function in promoting ciliogenesis. Human genetics studies suggest that both the TPR repeat region and the ASH domain are functionally important, but more work will be required to investigate the detailed structure and function of these domains. Finally, given the structural similarity between TRAPPCII ASH domains and the bacterial trafficking chaperone PapD of the usher pili assembly machinery, our results indicate that the TRAPPCII components may be evolutionarily related to PapD (Figure [6](#F6){ref-type="fig"}). This would be in line with the autogenous hypothesis of ciliary evolution in which it is suggested that cilia and IFT evolved from coated vesicle transport \[[@B57],[@B58]\].
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###### Additional file 1: Figure S1

Graphical output showing results of the initial HHpred search with human DLEC1 (residues 769-980) as search query. The amino acid sequence of human DLEC1 (residues 769-980) was used as a search query in HHpred. Profile-to-profile searches were obtained by three iterative PSI-BLAST searches against the PFAM database of HMM profiles. The figure shows a bar graph summarizing the positions and color-coded significances of the database matches with more than 40% probability. The bars are color-coded according to the significance of the hits (For details see <http://toolkit.tuebingen.mpg.de/hhpred>). From red meaning very significant to blue meaning not significant.
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